Innorna, a clinical-stage biotech company advancing RNA medicines, today announced that it has been nominated for the 2026 Prix Galien USA Best Startup Award.

The equity portion of the Fund rose (gross of fees) and outperformed its benchmark, the NASDAQ Biotechnology Index. Read more ...

New government funding from Pennsylvania to Kansas City is strengthening biotech hubs — but experts say money alone won’t ...

By Laura Gunter Carolina Journal North Carolina has spent decades building one of the nation’s leading life sciences economies — supporting high-paying jobs, advanced manufacturing, cutting-edge ...

Northern KY's life sciences sector grew 42%, driven by reshoring, logistics access, and lower costs. An expert explains the region's pitch to medtech.

73% say the top reason why sponsors are leaving the U.S. is delay and financial cost tied to FDA clinical holds and rework. Surveyed executives cite “current turmoil at the FDA with high turnover” and ...

A Miami biotech founder transforms advanced materials into consumer and clinical paths, using the city’s investor, health and Latin America connections to scale.

Over the past 30 years, the MSCA has funded over 150,000 researchers to pursue their ideas as part of doctoral training networks, postdoctoral fellowships and staff exchange programmes.

In GEN’s flagship virtual event, The State of Biotech, we hear from a distinguished group of business executives, award-winning scientists, and journalists.

Ying Huang is now running K2 Therapeutics, which has licensed multiple prospects from China-based biotechs and is searching for more “high-potential” medicines.

This is not possible without a steadfast commitment from our partners in the federal government and private industry. It’s important to acknowledge and evaluate the current constraints. On the ...

UC Santa Cruz deepens industry engagement to underscore its vital role in contributing basic research and tomorrow’s talent, convening its first international RNA biotech conference on August 18 ...